Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback